|
Delayed
Nasdaq Stockholm
10:54:06 13/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 9.120 SEK | +5.19% |
|
+3.40% | -32.44% |
| 09:17am | Vivesto narrowed its loss in the second quarter, CEO says: we are staying on plan | FW |
| 07:03am | Calendar for Thursday, August 13 | FW |
| Market Cap | 95.99M 10.05M 8.71M 8.16M 7.44M 13.99M 959M 14.21M 37.52M 480M 37.75M 36.93M 1.6B | P/E 2026 * |
-2.83x | P/E 2027 * | -2.07x |
|---|---|---|---|---|---|
| Enterprise Value | 87.99M 9.22M 7.98M 7.48M 6.82M 12.83M 879M 13.03M 34.39M 440M 34.6M 33.85M 1.47B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
52.67% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vivesto AB
| 1 day | +5.19% | ||
| 1 week | +3.40% | ||
| Current month | +8.83% | ||
| 1 month | +8.06% | ||
| 3 months | +8.57% | ||
| 6 months | -3.18% | ||
| Current year | -32.44% |
| 1 week | 8.67 |  | 9.14 |
| 1 month | 7.6 | | 9.14 |
| Current year | 7 | | 19.5 |
| 1 year | 7 | | 28 |
| 3 years | 7 | | 90.6 |
| 5 years | 7 | | 302.9 |
| 10 years | 7 | | 1,670 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 68 | 23/01/2023 |
Björn Svanström
DFI | Director of Finance/CFO | 55 | 01/07/2026 |
| Chief Tech/Sci/R&D Officer | 39 | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 25/05/2022 | |
Hege Hellstrom
BRD | Director/Board Member | 61 | 26/09/2019 |
Pål Ryfors
BRD | Director/Board Member | 43 | 25/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/25/22 A | Buy | Chief Executive Officer | 12,200 | 0.0027% | ||
| 3/24/22 A | Others | Chairman | 120,000 | 0.0268% | ||
| 12/20/21 A | Free | Chief Executive Officer | 2,250,000 | 0.5018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.19% | +3.40% | -62.31% | -64.02% | 10.05M | |
| +0.43% | +4.31% | +90.84% | +130.99% | 1,088B | |
| +0.41% | +1.27% | +50.98% | +50.05% | 629B | |
| -0.53% | +1.04% | +25.23% | +63.46% | 440B | |
| -0.37% | -0.16% | +45.81% | +37.47% | 359B | |
| -0.37% | -1.23% | +26.78% | +35.99% | 291B | |
| -0.67% | -1.79% | +1.70% | +4.71% | 245B | |
| +0.45% | +2.05% | +46.04% | +58.54% | 225B | |
| -0.43% | +1.72% | -8.36% | -51.78% | 204B | |
| +0.07% | +3.12% | +13.21% | +69.84% | 168B | |
| Average | +0.41% | +0.82% | +22.99% | +33.53% | 364.92B | |
| Weighted average by Cap. | +0.03% | +1.93% | +48.64% | +66.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -31M -3.25M -2.81M -2.64M -2.4M -4.52M -310M -4.59M -12.12M -155M -12.19M -11.93M -517M | -46M -4.82M -4.17M -3.91M -3.57M -6.71M -460M -6.81M -17.98M -230M -18.09M -17.7M -767M |
| Net Debt | -8M -838K -726K -680K -620K -1.17M -79.92M -1.18M -3.13M -40.02M -3.15M -3.08M -133M | -10M -1.05M -907K -850K -776K -1.46M -99.9M -1.48M -3.91M -50.02M -3.93M -3.85M -167M |
Employees
4
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/08/26 | SEK 9.120 | +5.19% | 3,665 |
| 12/08/26 | SEK 8.670 | -1.25% | 14,121 |
| 11/08/26 | SEK 8.780 | -2.34% | 2,744 |
| 10/08/26 | SEK 8.990 | +3.33% | 22,689 |
| 07/08/26 | SEK 8.700 | -1.36% | 13,151 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIVE Stock
Select your edition
All financial news and data tailored to specific country editions
